Search
for
Sort by
Research 151–180 of 1000+
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- The role of janus kinases in the treatment of autoimmune skin diseases
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- JAK inhibitors and alopecia areata
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- Alopecia universalis. Partial response to tofacitinib
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Under Development JAK Inhibitors for Dermatologic Diseases
- Topical tofacitinib in treatment of alopecia areata
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Jak inhibitors in the treatment of alopecia areata - a literature review
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.